Rewards
All
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
My Bing
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Pfizer, AstraZeneca
Pfizer Wins $107.5M Verdict Against AstraZeneca Over Cancer Drug Patent Dispute
A Delaware federal jury has determined that AstraZeneca Plc (NASDAQ:AZN) must pay Pfizer Inc (NYSE:PFE) $107.5 million in damages, concluding that AstraZeneca’s blockbuster lung cancer drug, Tagrisso,
Pfizer wins $107.5 million from AstraZeneca in US cancer drug patent trial
AstraZeneca owes Pfizer $107.5 million in damages, a Delaware federal jury said on Friday after finding that AstraZeneca's blockbuster lung cancer drug Tagrisso violated its Wyeth unit's patent rights.
Pfizer to Settle 10K Lawsuits Over Drug Linked to Cancer, Costing Company Millions
Big Pharma giant Pfizer confirmed on Wednesday that it will settle more than 10,000 lawsuits over allegations that the company
Pfizer to pay $250M to settle more than 10,000 lawsuits over cancer risks in Zantac
It looks like pharmaceutical company Pfizer will pay $250 million to settle more than 10,000 lawsuits filed over a heartburn drug it used to sell that has been linked to cancer risk, per a Financial Times report citing people familiar with the deal.
Pfizer offers up to $250 mln to settle Zantac cancer lawsuits, FT reports
Pfizer will pay up to $250 million to settle more than 10,000 U.S. lawsuits over cancer risks associated with its discontinued heartburn drug Zantac, the Financial Times reported on Thursday.
2h
Pfizer Unusual Options Activity
Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from ...
BioSpace
8h
AstraZeneca to Pay Pfizer $107.5M in Damages in Tagrisso Patent Tussle
Pfizer’s Wyeth unit notched a legal victory over AstraZenca on Friday as a federal jury found the British-Swedish company ...
2d
on MSN
Moderna wins a battle in vaccine patent dispute with Pfizer-BioNTech
Moderna said Friday that the European Patent Office has upheld the validity of one of its key patents, a victory in a ...
3d
Pfizer: Potential Double-Digit Upside Combined With High Dividend Yield
Pfizer has efficiently cut costs down to boost guidance. Read why PFE stock is a great option for dividend growth-focused ...
7d
on MSN
Want $1,000 in Dividend Income? Here's How Much You'd Have to Invest in Pfizer Stock
With the current dividend yield at 5.9%, you would need to invest around $17,000 into Pfizer stock to earn $1,000 in annual ...
Tribune-Star
2d
Historical Treasure: 1955 Pfizer medal depicts life-saving bacterium
This week’s Historical Treasure is a CLIN-BYLA Pfizer medal that depicts a colony of the bacterium Streptomyces Rimosus on ...
3d
Pfizer Stock: Rebound Has Started (Technical Analysis)
Pfizer's earnings and sales have fallen due to decreased demand for COVID-19 products. Click here to read why PFE's pipeline ...
FiercePharma
9h
Pfizer unit wins $107.5M verdict in cancer-drug patent case against AstraZeneca
A Delaware federal jury has ordered AstraZeneca to fork over $107.5 million to
Pfizer
for infringing two of the latter ...
3d
How the love story between von der Leyen and Pfizer turned sour
From making her Europe’s vaccine saviour to becoming a skeleton in her closet: All the ebbs and flows in the love story ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Related topics
AstraZeneca
Moderna
Zantac
COVID
BioNTech